PDCD1 and neoplasm: These mechanisms include alterations in the tumor microenvironment that create an immunosuppressive state, mutations in genes involved in the PD-1/PD-L1 pathway, expression of alternative immune checkpoints, or changes in metabolic pathways affecting immune cell function (Lei et al., 2020[50]).